Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day:
CASSIOPEIA study results of MALDI-TOF mass spec vs bone marrow MRD for monitoring support phase-adapted MS role enabling frequent non-invasive monitoring in maintenance w/ BM assessment when maximum sensitivity needed.”
Title: Blood-based MALDI-TOF mass spectrometry versus bone marrow MRD for monitoring multiple myeloma: CASSIOPEIA study results
Authors: Thomas Dejoie, Neila Rebouh, Jill Corre, Soraya Wuilleme, Françoise Kraeber-Bodere, Cyrille Hulin, Aurore Perrot, Cyrille Touzeau, Xavier P. Leleu, Bertrand Arnulf, Lionel Karlin, Philippe Moreau, Helene Caillon
You can read the full article on Blood.
You can find other articles featuring Robert Orlowski on OncoDaily.
